These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32275975)

  • 1. Defining the Prognostic Role of MicroRNAs in Cutaneous Melanoma.
    Dika E; Riefolo M; Porcellini E; Broseghini E; Ribero S; Senetta R; Osella-Abate S; Scarfì F; Lambertini M; Veronesi G; Patrizi A; Fanti PA; Ferracin M
    J Invest Dermatol; 2020 Nov; 140(11):2260-2267. PubMed ID: 32275975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of miR-146a-5p and miR-21-5p with Prognostic Features in Melanomas.
    Naddeo M; Broseghini E; Venturi F; Vaccari S; Corti B; Lambertini M; Ricci C; Fontana B; Durante G; Pariali M; Scotti B; Milani G; Campione E; Ferracin M; Dika E
    Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
    Larsen AC
    Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiRNAs as Potential Prognostic Biomarkers for Metastasis in Thin and Thick Primary Cutaneous Melanomas.
    Valentini V; Zelli V; Gaggiano E; Silvestri V; Rizzolo P; Bucalo A; Calvieri S; Grassi S; Frascione P; Donati P; Soda G; Ottini L; Richetta AG
    Anticancer Res; 2019 Aug; 39(8):4085-4093. PubMed ID: 31366492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs expression associated with aggressive clinicopathological features and poor prognosis in primary cutaneous melanomas.
    Murria Estal R; de Unamuno Bustos B; Pérez Simó G; Simarro Farinos J; Torres Navarro I; Alegre de Miquel V; Ballester Sánchez R; Sabater Marco V; Llavador Ros M; Palanca Suela S; Botella Estrada R
    Melanoma Res; 2021 Feb; 31(1):18-26. PubMed ID: 33234848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A preliminary study of microRNA expression in different types of primary melanoma.
    Gencia I; Baderca F; Avram S; Gogulescu A; Marcu A; Seclaman E; Marian C; Solovan C
    Bosn J Basic Med Sci; 2020 May; 20(2):197-208. PubMed ID: 31479413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unraveling the role of microRNA/isomiR network in multiple primary melanoma pathogenesis.
    Dika E; Broseghini E; Porcellini E; Lambertini M; Riefolo M; Durante G; Loher P; Roncarati R; Bassi C; Misciali C; Negrini M; Rigoutsos I; Londin E; Patrizi A; Ferracin M
    Cell Death Dis; 2021 May; 12(5):473. PubMed ID: 33980826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Expression of miR-211-5p in Sentinel Lymph Node Metastases of Malignant Melanoma Is a Potential Marker for Poor Prognosis.
    Moritz RKC; Ebelt N; Rattay T; Ehrenreich J; Sunderkötter C; Gerloff D
    Int J Mol Sci; 2024 Oct; 25(19):. PubMed ID: 39409187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological predictors of recurrence in nodular and superficial spreading cutaneous melanoma: a multivariate analysis of 214 cases.
    Pizzichetta MA; Massi D; Mandalà M; Queirolo P; Stanganelli I; De Giorgi V; Ghigliotti G; Cavicchini S; Quaglino P; Corradin MT; Rubegni P; Alaibac M; Astorino S; Ayala F; Magi S; Mazzoni L; Manganoni MA; Talamini R; Serraino D; Palmieri G;
    J Transl Med; 2017 Nov; 15(1):227. PubMed ID: 29115977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Markers in Melanoma Progression: A Study on the Expression of miRNA Gene Subtypes in Tumoral vs. Benign Nevi.
    Prodan M; Costescu S; Elagez A; Laitin SMD; Bloanca V; Crainiceanu Z; Seclaman E; Toma AO; Fericean RM; Puenea G; Cozma GV
    Curr Oncol; 2024 May; 31(5):2881-2894. PubMed ID: 38785501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA expression profiles associated with mutational status and survival in malignant melanoma.
    Caramuta S; Egyházi S; Rodolfo M; Witten D; Hansson J; Larsson C; Lui WO
    J Invest Dermatol; 2010 Aug; 130(8):2062-70. PubMed ID: 20357817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of Common microRNA Biomarker Candidates in Stage IV Melanoma Patients and a Human Melanoma Cell Line: A Potential Anti-Melanoma Agent Screening Model.
    Antonova E; Hambikova A; Shcherbakov D; Sukhov V; Vysochanskaya S; Fadeeva I; Gorshenin D; Sidorova E; Kashutina M; Zhdanova A; Mitrokhin O; Avvakumova N; Zhernov Y
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
    Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
    Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of sentinel lymph node biopsy according to Breslow thickness for cutaneous melanoma.
    Stiegel E; Xiong D; Ya J; Funchain P; Isakov R; Gastman B; Vij A
    J Am Acad Dermatol; 2018 May; 78(5):942-948. PubMed ID: 29408526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA Expression in Formalin-Fixed, Paraffin-Embedded Samples of Canine Cutaneous and Oral Melanoma by RT-qPCR.
    Zamarian V; Catozzi C; Ressel L; Finotello R; Ceciliani F; Vilafranca M; Altimira J; Lecchi C
    Vet Pathol; 2019 Nov; 56(6):848-855. PubMed ID: 31526125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA-10b is a prognostic biomarker for melanoma.
    Saldanha G; Elshaw S; Sachs P; Alharbi H; Shah P; Jothi A; Pringle JH
    Mod Pathol; 2016 Feb; 29(2):112-21. PubMed ID: 26743475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma.
    Kitago M; Martinez SR; Nakamura T; Sim MS; Hoon DS
    Clin Cancer Res; 2009 May; 15(9):2988-94. PubMed ID: 19336521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signatures of microRNAs and selected microRNA target genes in human melanoma.
    Philippidou D; Schmitt M; Moser D; Margue C; Nazarov PV; Muller A; Vallar L; Nashan D; Behrmann I; Kreis S
    Cancer Res; 2010 May; 70(10):4163-73. PubMed ID: 20442294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma MicroRNA signature predicts post-recurrence survival.
    Segura MF; Belitskaya-Lévy I; Rose AE; Zakrzewski J; Gaziel A; Hanniford D; Darvishian F; Berman RS; Shapiro RL; Pavlick AC; Osman I; Hernando E
    Clin Cancer Res; 2010 Mar; 16(5):1577-86. PubMed ID: 20179230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in microRNA expression between melanoma and healthy adjacent skin.
    Aksenenko M; Palkina N; Komina A; Tashireva L; Ruksha T
    BMC Dermatol; 2019 Jan; 19(1):1. PubMed ID: 30611259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.